跳至主要内容
临床试验/NCT00795873
NCT00795873已完成不适用

OVATIO CRT and SITUS OTW LV Lead Post Approval Study

ELA Medical, Inc.33 个研究点 分布在 1 个国家目标入组 2,260 人开始时间: 2008年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
2,260
试验地点
33
主要终点
SITUS OTW LV lead complication free rate

研究概览

简要总结

Post approval study measuring safety outcomes on the Ovatio CRT-D and SITUS OTW LV lead over 5 years.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • NYHA Class III/IV
  • Stable medical regimen
  • QRS greater than or equal to 130 ms
  • LVEF less than or equal to 35%

排除标准

  • VT of transient or reversible causes
  • Incessant VT
  • Currently implanted with a lead positioned through the coronary sinus (unless it is the SITUS OTW LV lead)
  • Cardiac revascularization or angioplasty within the last month
  • Heart failure due to correctable valve disease
  • Chronic, medially refractory AT
  • Enrolled in another clinical study that may confound the results of this study
  • Life expectancy less than 6 months
  • Inability to understand the purpose of the study or refusal to cooperate
  • Inability or refusal to provide informed consent
  • Unavailable for scheduled follow-up with the implanting practice
  • Sensitivity to 1 mg dexamethasone sodium phosphate
  • Less than 18 years of age
  • Pregnancy

结局指标

主要结局

SITUS OTW LV lead complication free rate

时间窗: 5 years

次要结局

  • System complication free rate(6 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (33)

Loading locations...

相似试验